Vanamala, K.; Bhise, K.; Sanchez, H.; Kebriaei, R.; Luong, D.; Sau, S.; Abdelhady, H.; Rybak, M.J.; Andes, D.; Iyer, A.K.
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus. Pharmaceutics 2021, 13, 1791.
https://doi.org/10.3390/pharmaceutics13111791
AMA Style
Vanamala K, Bhise K, Sanchez H, Kebriaei R, Luong D, Sau S, Abdelhady H, Rybak MJ, Andes D, Iyer AK.
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus. Pharmaceutics. 2021; 13(11):1791.
https://doi.org/10.3390/pharmaceutics13111791
Chicago/Turabian Style
Vanamala, Kushal, Ketki Bhise, Hiram Sanchez, Razieh Kebriaei, Duy Luong, Samaresh Sau, Hosam Abdelhady, Michael J. Rybak, David Andes, and Arun K. Iyer.
2021. "Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus" Pharmaceutics 13, no. 11: 1791.
https://doi.org/10.3390/pharmaceutics13111791
APA Style
Vanamala, K., Bhise, K., Sanchez, H., Kebriaei, R., Luong, D., Sau, S., Abdelhady, H., Rybak, M. J., Andes, D., & Iyer, A. K.
(2021). Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus. Pharmaceutics, 13(11), 1791.
https://doi.org/10.3390/pharmaceutics13111791